{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T04:13:45Z","timestamp":1772165625519,"version":"3.50.1"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,6,4]],"date-time":"2025-06-04T00:00:00Z","timestamp":1748995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,6,4]],"date-time":"2025-06-04T00:00:00Z","timestamp":1748995200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Gastroenterol"],"DOI":"10.1186\/s12876-025-03934-8","type":"journal-article","created":{"date-parts":[[2025,6,4]],"date-time":"2025-06-04T01:50:05Z","timestamp":1749001805000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["A risk prediction model for nausea and vomiting after TACE: a cross-sectional study"],"prefix":"10.1186","volume":"25","author":[{"given":"Yali","family":"Dai","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mengting","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hong","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miao","family":"Cai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,6,4]]},"reference":[{"key":"3934_CR1","doi-asserted-by":"publisher","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. (2021) Global Cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries CA: a cancer journal for clinicians 71: 209\u201349. https:\/\/doi.org\/10.3322\/caac.21660","DOI":"10.3322\/caac.21660"},{"key":"3934_CR2","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1016\/j.semcancer.2021.07.017","volume":"86","author":"GP Nagaraju","year":"2022","unstructured":"Nagaraju GP, Dariya B, Kasa P, Peela S, El-Rayes BF. Epigenetics in hepatocellular carcinoma seminars. cancer Biology. 2022;86:622\u201332. https:\/\/doi.org\/10.1016\/j.semcancer.2021.07.017.","journal-title":"cancer Biology"},{"key":"3934_CR3","doi-asserted-by":"publisher","first-page":"2471","DOI":"10.1002\/ijc.31280","volume":"142","author":"D Maucort-Boulch","year":"2018","unstructured":"Maucort-Boulch D, de Martel C, Franceschi S, Plummer M. Fraction and incidence of liver cancer attributable to hepatitis B and C viruses worldwide. Int J Cancer. 2018;142:2471\u20137. https:\/\/doi.org\/10.1002\/ijc.31280.","journal-title":"Int J Cancer"},{"key":"3934_CR4","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.ctrv.2018.11.002","volume":"72","author":"JL Raoul","year":"2019","unstructured":"Raoul JL, Forner A, Bolondi L, Cheung TT, Kloeckner R, de Baere T. Updated use of TACE for hepatocellular carcinoma treatment: how and when to use it based on clinical evidence. Cancer Treat Rev. 2019;72:28\u201336. https:\/\/doi.org\/10.1016\/j.ctrv.2018.11.002.","journal-title":"Cancer Treat Rev"},{"key":"3934_CR5","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.3348\/kjr.2022.0822","volume":"23","author":"KLCAKNCCN Korea","year":"2022","unstructured":"Korea KLCAKNCCN. 2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma Korean. J Radiol. 2022;23:1126\u2013240. https:\/\/doi.org\/10.3348\/kjr.2022.0822.","journal-title":"J Radiol"},{"issue":"7","key":"3934_CR6","doi-asserted-by":"publisher","first-page":"606","DOI":"10.3348\/kjr.2023.0385","volume":"24","author":"Y Cho","year":"2023","unstructured":"Cho Y, Choi JW, Kwon H, et al. Transarterial chemoembolization for hepatocellular carcinoma: 2023 expert Consensus-Based practical recommendations of the Korean liver Cancer Association[J]. Korean J Radiol. 2023;24(7):606\u201325.","journal-title":"Korean J Radiol"},{"key":"3934_CR7","doi-asserted-by":"publisher","unstructured":"Roehlen N, Stoehr F, M\u00fcller L, Luxenburger H, Gairing SJ, Reincke M, Schultheiss M, Berisha F, Weinmann A, Foerster F, Marquardt JU, Thimme R, Galle PR, Bettinger D, Kloeckner R. Prediction of postembolization syndrome after transarterial chemoembolization of hepatocellular carcinoma and its impact on prognosis. Hepatol Commun. 2023;7. https:\/\/doi.org\/10.1097\/hc9.0000000000000252.","DOI":"10.1097\/hc9.0000000000000252"},{"key":"3934_CR8","doi-asserted-by":"publisher","unstructured":"Lu H, Zheng C, Liang B, Xiong B. Mechanism and risk factors of nausea and vomiting after TACE: a retrospective analysis. BMC Cancer. 2021;21(513). https:\/\/doi.org\/10.1186\/s12885-021-08253-1.","DOI":"10.1186\/s12885-021-08253-1"},{"key":"3934_CR9","doi-asserted-by":"publisher","unstructured":"Blackburn H, West S. Management of postembolization syndrome following hepatic transarterial chemoembolization for primary or metastatic liver Cancer. Cancer Nurs. 2016;39(E1\u2013e18). https:\/\/doi.org\/10.1097\/ncc.0000000000000302.","DOI":"10.1097\/ncc.0000000000000302"},{"key":"3934_CR10","doi-asserted-by":"publisher","unstructured":"Apfel CC, L\u00e4\u00e4r\u00e4 E, Koivuranta M, Greim CA, Roewer N. (1999) A simplified risk score for predicting postoperative nausea and vomiting: conclusions from cross-validations between two centers Anesthesiology 91: 693\u2013700. https:\/\/doi.org\/10.1097\/00000542-199909000-00022.","DOI":"10.1097\/00000542-199909000-00022"},{"key":"3934_CR11","doi-asserted-by":"publisher","unstructured":"Craig SS, Dalziel SR, Powell CV, Graudins A, Babl FE, Lunny C. (2020) Interventions for escalation of therapy for acute exacerbations of asthma in children: an overview of Cochrane reviews the Cochrane database of systematic reviews 8: Cd012977. https:\/\/doi.org\/10.1002\/14651858.CD012977.pub2","DOI":"10.1002\/14651858.CD012977.pub2"},{"key":"3934_CR12","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1016\/s0895-4356(96)00236-3","volume":"49","author":"P Peduzzi","year":"1996","unstructured":"Peduzzi P, Concato J, Kemper E, Holford TR, Feinstein AR. A simulation study of the number of events per variable in logistic regression analysis. J Clin Epidemiol. 1996;49:1373\u20139. https:\/\/doi.org\/10.1016\/s0895-4356(96)00236-3.","journal-title":"J Clin Epidemiol"},{"key":"3934_CR13","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1177\/1740774520975120","volume":"18","author":"E Basch","year":"2021","unstructured":"Basch E, Becker C, Rogak LJ, Schrag D, Reeve BB, Spears P, Smith ML, Gounder MM, Mahoney MR, Schwartz GK, Bennett AV, Mendoza TR, Cleeland CS, Sloan JA, Bruner DW, Schwab G, Atkinson TM, Thanarajasingam G, Bertagnolli MM, Dueck AC. Composite grading algorithm for the National Cancer institute\u2019s Patient-Reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE). Clin Trials. 2021;18:104\u201314. https:\/\/doi.org\/10.1177\/1740774520975120.","journal-title":"Clin Trials"},{"key":"3934_CR14","doi-asserted-by":"publisher","first-page":"5995","DOI":"10.7314\/apjcp.2013.14.10.5995","volume":"14","author":"SY Wang","year":"2013","unstructured":"Wang SY, Zhu WH, Vargulick S, Lin SB, Meng ZQ. Nausea and vomiting after transcatheter arterial chemoembolization for hepatocellular carcinoma: incidence and risk factor analysis. Asian Pac J cancer Prevention: APJCP. 2013;14:5995\u20136000. https:\/\/doi.org\/10.7314\/apjcp.2013.14.10.5995.","journal-title":"Asian Pac J cancer Prevention: APJCP"},{"key":"3934_CR15","doi-asserted-by":"publisher","unstructured":"Gan TJ, Belani KG, Bergese S, Chung F, Diemunsch P, Habib AS, Jin Z, Kovac AL, Meyer TA, Urman RD, Apfel CC, Ayad S, Beagley L, Candiotti K, Englesakis M, Hedrick TL, Kranke P, Lee S, Lipman D, Minkowitz HS, Morton J, Philip BK. (2020) Fourth consensus guidelines for the management of postoperative nausea and vomiting anesthesia and analgesia 131: 411\u201348. https:\/\/doi.org\/10.1213\/ane.0000000000004833","DOI":"10.1213\/ane.0000000000004833"},{"key":"3934_CR16","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.1093\/annonc\/mdx100","volume":"28","author":"G Dranitsaris","year":"2017","unstructured":"Dranitsaris G, Molassiotis A, Clemons M, Roeland E, Schwartzberg L, Dielenseger P, Jordan K, Young A, Aapro M. The development of a prediction tool to identify cancer patients at high risk for chemotherapy-induced nausea and vomiting annals of oncology: official. J Eur Soc Med Oncol. 2017;28:1260\u20137. https:\/\/doi.org\/10.1093\/annonc\/mdx100.","journal-title":"J Eur Soc Med Oncol"},{"key":"3934_CR17","doi-asserted-by":"publisher","unstructured":"Singh P, Yoon SS, Kuo B. (2016) Nausea: a review of pathophysiology and therapeutics therapeutic advances in gastroenterology 9: 98\u2013112. https:\/\/doi.org\/10.1177\/1756283x15618131","DOI":"10.1177\/1756283x15618131"},{"key":"3934_CR18","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1111\/aas.12552","volume":"59","author":"HB da Silva","year":"2015","unstructured":"da Silva HB, Sousa AM, Guimar\u00e3es GM, Slullitel A, Ashmawi HA. Does previous chemotherapy-induced nausea and vomiting predict postoperative nausea and vomiting? Acta Anaesthesiol Scand. 2015;59:1145\u201353. https:\/\/doi.org\/10.1111\/aas.12552.","journal-title":"Acta Anaesthesiol Scand"},{"key":"3934_CR19","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1002\/hep.28453","volume":"64","author":"R Lencioni","year":"2016","unstructured":"Lencioni R, de Baere T, Soulen MC, Rilling WS, Geschwind JF. Lipiodol transarterial chemoembolization for hepatocellular carcinoma: A systematic review of efficacy and safety data hepatology. (Baltimore Md). 2016;64:106\u201316. https:\/\/doi.org\/10.1002\/hep.28453.","journal-title":"(Baltimore Md)"},{"key":"3934_CR20","doi-asserted-by":"publisher","first-page":"34","DOI":"10.3348\/kjr.2018.0088","volume":"20","author":"YM Nouri","year":"2019","unstructured":"Nouri YM, Kim JH, Yoon HK, Ko HK, Shin JH, Gwon DI. Update on transarterial chemoembolization with Drug-Eluting microspheres for hepatocellular carcinoma Korean. J Radiol. 2019;20:34\u201349. https:\/\/doi.org\/10.3348\/kjr.2018.0088.","journal-title":"J Radiol"},{"key":"3934_CR21","doi-asserted-by":"publisher","first-page":"808","DOI":"10.4254\/wjh.v9.i18.808","volume":"9","author":"JE Song","year":"2017","unstructured":"Song JE, Kim DY. Conventional vs drug-eluting beads transarterial chemoembolization for hepatocellular carcinoma world. J Hepatol. 2017;9:808\u201314. https:\/\/doi.org\/10.4254\/wjh.v9.i18.808.","journal-title":"J Hepatol"},{"key":"3934_CR22","doi-asserted-by":"publisher","first-page":"100278","DOI":"10.1016\/j.ctarc.2020.100278","volume":"26","author":"K Gupta","year":"2021","unstructured":"Gupta K, Walton R, Kataria SP. Chemotherapy-Induced nausea and vomiting: pathogenesis, recommendations, and new trends. Cancer Treat Res Commun. 2021;26:100278. https:\/\/doi.org\/10.1016\/j.ctarc.2020.100278.","journal-title":"Cancer Treat Res Commun"},{"key":"3934_CR23","doi-asserted-by":"publisher","first-page":"521","DOI":"10.3350\/cmh.2023.0202","volume":"29","author":"Y Cho","year":"2023","unstructured":"Cho Y, Choi JW, Kwon H, Kim KY, Lee BC, Chu HH, Lee DH, Lee HA, Kim GM, Oh JS, Hyun D, Lee IJ, Rhim H. Transarterial chemoembolization for hepatocellular carcinoma: 2023 expert consensus-based practical recommendations of the Korean liver Cancer association. Clin Mol Hepatol. 2023;29:521\u201341. https:\/\/doi.org\/10.3350\/cmh.2023.0202.","journal-title":"Clin Mol Hepatol"},{"key":"3934_CR24","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1007\/s005200050232","volume":"7","author":"N Sohara","year":"1999","unstructured":"Sohara N, Takagi H, Abe T, Hashimoto Y, Kojima A, Takahashi H, Nagamine T, Mori M. Nausea and vomiting induced by arterial chemo-embolization in patients with hepatocellular carcinoma and the antiemetic effect of Ondansetron hydrochloride supportive care in cancer. Official J Multinational Association Supportive Care Cancer. 1999;7:84\u20138. https:\/\/doi.org\/10.1007\/s005200050232.","journal-title":"Official J Multinational Association Supportive Care Cancer"},{"key":"3934_CR25","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1097\/00000542-199207000-00023","volume":"77","author":"MF Watcha","year":"1992","unstructured":"Watcha MF, White PF. Postoperative nausea and vomiting. Its etiology, treatment. Prev Anesthesiology. 1992;77:162\u201384. https:\/\/doi.org\/10.1097\/00000542-199207000-00023.","journal-title":"Prev Anesthesiology"},{"key":"3934_CR26","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1148\/radiol.2018180257","volume":"290","author":"MH Khalaf","year":"2019","unstructured":"Khalaf MH, Sundaram V, AbdelRazek Mohammed MA, Shah R, Khosla A, Jackson K, Desai M, Kothary N. A predictive model for postembolization syndrome after transarterial hepatic chemoembolization of hepatocellular carcinoma. Radiology. 2019;290:254\u201361. https:\/\/doi.org\/10.1148\/radiol.2018180257.","journal-title":"Radiology"},{"key":"3934_CR27","doi-asserted-by":"publisher","first-page":"102355","DOI":"10.1016\/j.ejon.2023.102355","volume":"66","author":"QQ Du","year":"2023","unstructured":"Du QQ, Liang M, Jiang B, Zhang M, Yu XL, Li X, Hao JH. Incidence and predictors of abdominal pain after transarterial chemoembolization of hepatocellular carcinoma: a single-center retrospective study. Eur J Oncol Nursing: Official J Eur Oncol Nurs Soc. 2023;66:102355. https:\/\/doi.org\/10.1016\/j.ejon.2023.102355.","journal-title":"Eur J Oncol Nursing: Official J Eur Oncol Nurs Soc"},{"key":"3934_CR28","doi-asserted-by":"publisher","first-page":"883","DOI":"10.6004\/jnccn.2017.0117","volume":"15","author":"MJ Berger","year":"2017","unstructured":"Berger MJ, Ettinger DS, Aston J, Barbour S, Bergsbaken J, Bierman PJ, Brandt D, Dolan DE, Ellis G, Kim EJ, Kirkegaard S, Kloth DD, Lagman R, Lim D, Loprinzi C, Ma CX, Maurer V, Michaud LB, Nabell LM, Noonan K, Roeland E, Rugo HS, Schwartzberg LS, Scullion B, Timoney J, Todaro B, Urba SG, Shead DA, Hughes M. NCCN guidelines insights: antiemesis, version 2.2017. J Natl Compr Cancer Network: JNCCN. 2017;15:883\u201393. https:\/\/doi.org\/10.6004\/jnccn.2017.0117.","journal-title":"J Natl Compr Cancer Network: JNCCN"},{"key":"3934_CR29","doi-asserted-by":"publisher","unstructured":"Moons KG, Kengne AP, Woodward M, Royston P, Vergouwe Y, Altman DG, Grobbee DE. Risk prediction models: I. Development, internal validation, and assessing the incremental value of a new (bio)marker. Heart. 2012;98:683\u201390. https:\/\/doi.org\/10.1136\/heartjnl-2011-301246.","DOI":"10.1136\/heartjnl-2011-301246"},{"key":"3934_CR30","doi-asserted-by":"publisher","first-page":"7773","DOI":"10.1007\/s00520-022-07221-0","volume":"30","author":"MS Kim","year":"2022","unstructured":"Kim MS, Uhm JY. Impact of discriminant factors on the comfort-care of nurses caring for trans-arterial chemoembolisation patients supportive care in cancer. Official J Multinational Association Supportive Care Cancer. 2022;30:7773\u201381. https:\/\/doi.org\/10.1007\/s00520-022-07221-0.","journal-title":"Official J Multinational Association Supportive Care Cancer"}],"container-title":["BMC Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-025-03934-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12876-025-03934-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-025-03934-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,4]],"date-time":"2025-06-04T01:50:06Z","timestamp":1749001806000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcgastroenterol.biomedcentral.com\/articles\/10.1186\/s12876-025-03934-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,4]]},"references-count":30,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3934"],"URL":"https:\/\/doi.org\/10.1186\/s12876-025-03934-8","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-5131480\/v1","asserted-by":"object"}]},"ISSN":["1471-230X"],"issn-type":[{"value":"1471-230X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,4]]},"assertion":[{"value":"22 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"It was approved by The Second Affiliated Hospital of Nanchang University\u2019s ethics committee (Approval No. O-Medical Research Ethics Review [2023] No. (24)). This study adhered to the Declaration of Helsinki in its procedures. All participants in this study provided informed consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"427"}}